SALIX PHARMACEUTICALS LTD DEL
SLXP
SLXP was delisted on the 31st of March, 2015.
298 hedge funds and large institutions have $11B invested in SALIX PHARMACEUTICALS LTD DEL in 2015 Q1 according to their latest regulatory filings, with 87 funds opening new positions, 77 increasing their positions, 115 reducing their positions, and 131 closing their positions.
236% more funds holding in top 10
Funds holding in top 10: 14 → 47 (+33)
147% more call options, than puts
Call options by funds: $3.77B | Put options by funds: $1.52B
35% more capital invested
Capital invested by funds: $8.13B → $11B (+$2.84B)
14% less funds holding
Funds holding: 347 → 298 (-49)
33% less repeat investments, than reductions
Existing positions increased: 77 | Existing positions reduced: 115
34% less first-time investments, than exits
New positions opened: 87 | Existing positions closed: 131
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Pentwater Capital Management
Naples,
Florida
|
+$333M |
| 2 |
UOC
UBS O'Connor
Chicago,
Illinois
|
+$230M |
| 3 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$213M |
| 4 |
MCM
Mason Capital Management
New York
|
+$203M |
| 5 |
HP
Hound Partners
New York
|
+$196M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Visium Asset Management
New York
|
-$354M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$344M |
| 3 |
Viking Global Investors
Stamford,
Connecticut
|
-$200M |
| 4 |
O
OppenheimerFunds
New York
|
-$174M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$170M |
SLXP Hedge Fund Activity: Q1 2015 in Review
298 of the 3,770 institutional investors tracked by Wall St. Rank reported a position in SALIX PHARMACEUTICALS LTD DEL (SLXP) for Q1 2015, worth a combined $11B — up 35% from $8.13B a quarter earlier.
Sellers outnumbered buyers: 131 funds closed out of SLXP and 87 opened new positions — a net loss of 44 holders — while 115 trimmed existing stakes and 77 added.
The largest buyer was Pentwater Capital Management, adding an estimated $333M. The largest seller was Visium Asset Management, exiting entirely with an estimated $354M sold.
- 298 institutional investors held SALIX PHARMACEUTICALS LTD DEL (SLXP) as of Q1 2015, down from 347 in Q4 2014.
- Funds reported $11B of SALIX PHARMACEUTICALS LTD DEL stock for Q1 2015, up 35% quarter-over-quarter.
- 87 funds opened new SALIX PHARMACEUTICALS LTD DEL positions in Q1 2015 and 131 closed out, a net change of -44 holders.
- The largest SALIX PHARMACEUTICALS LTD DEL buyer in Q1 2015 was Pentwater Capital Management, an estimated $333M added.
- The largest SALIX PHARMACEUTICALS LTD DEL seller in Q1 2015 was Visium Asset Management, an estimated $354M sold.
Based on aggregated 13F filings for Q1 2015.